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Signals Transduced by Ca2/Calcineurin and
NFATc3/c4 Pattern the Developing Vasculature
paths that meet and probably anticipate the oxygenation
needs of the growing tissues of the embryo. The mecha-
nisms underlying these patterning events are poorly un-
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derstood, and many of the mutations that interfere withDepartment of Pathology
angiogenesis do not affect the patterning of vessels.Howard Hughes Medical Institute
For example, in Tie-2 and Ang-1 mutant mice, growingStanford University
vessels continue to observe somitic boundaries even inStanford, California 94305
the face of fatal defects in angiogenesis. The determina-
tion of arterial and venous identity and the essential
interconnections between them are established beforeSummary
the heart begins to move blood effectively and occurs
by the selective expression of and signaling by ephrin-Vascular development requires an orderly exchange of
B2 on arteries and Eph-B4 on veins (Adams et al., 1999,signals between growing vessels and their supporting
2001; Gerety et al., 1999; Wang et al., 1998).tissues, but little is known of the intracellular signaling
Despite these major advances in the identification ofpathways underlying this communication. We find that
crucial growth factors and their receptors, the intracellu-mice with disruptions of both NFATc4 and the related
lar signaling pathways critical for vascular developmentNFATc3 genes die around E11 with generalized de-
are still largely obscure. The paucity of information onfects in vessel assembly as well as excessive and dis-
signaling mechanisms in vascular development and an-organized growth of vessels into the neural tube and
giogenesis under pathological conditions in the adult issomites. Since calcineurin is thought to control nu-
surprising in light of the fact that most of the receptorsclear localization of NFATc proteins, we introduced a
involved are tyrosine kinases, which should activatemutation into the calcineurin B gene that prevents
both MAP kinase cascades and Ca2 signaling. In a num-phosphatase activation by Ca2 signals. These CnB
ber of tissues, Ca2 and ras signals are integrated in themutant mice exhibit vascular developmental abnor-
nucleus by the assembly of NFAT transcription com-malities similar to the NFATc3/c4 null mice. We show
plexes from nuclear components (NFATn), which arethat calcineurin function is transiently required be-
dependent upon ras or PKC signaling, with the cyto-tween E7.5 and E8.5. Hence, early calcineurin/NFAT
plasmic components (NFATc), which are dependent onsignaling initiates the later cross-talk between vessels
Ca2 and calcineurin signals. (Crabtree, 1999; Flanaganand surrounding tissues that pattern the vasculature.
et al., 1991; Rao et al., 1997). Ca2 signals lead to the
activation of calcineurin and the rapid dephosphoryla-Introduction
tion and nuclear import of the products of the four NFATc
genes (NFATc1-c4, Hugo Nomenclature Committee).The development of the vertebrate vascular system re-
Although the Ca2/calcineurin/NFAT signaling path-quires an ordered series of signals that direct the differ-
way was one of the first to be defined, genetic redun-entiation of endothelial cells and formation of a primitive
dancy has made it difficult to study. In addition, cal-endothelial vascular plexus by a process called vasculo-
cineurin phosphatase activity is induced by a complexgenesis. The subsequent stages of vascular develop-
process. Upon reaching a threshold of about 400 nM,ment, summarized as angiogenesis, involve a series of
Ca2 binds to both calmodulin and CnB displacing themorphogenetic events which give rise to the anatomi-
inhibitory C-terminal peptide from the active site of CnA
cally highly stereotyped hierarchical network of mature
and activating phosphatase function (Klee et al., 1979,
vessels composed of endothelial cells and perivascular
1998). CnB thus acts as a sensor for changes in intracel-
supporting cells (Folkman and D’Amore, 1996; Yanco- lular Ca2. The catalytic component CnA is encoded by
poulos et al., 2000). Vascular endothelial growth factor three genes, while CnB is encoded by two genes. One
(VEGF) (Carmeliet et al., 1996a; Ferrara et al., 1996) and of the CnB genes is ubiquitously expressed, while the
its tyrosine kinase receptors VEGF-R2/Flk-1 (Shalaby et other is testis specific. The immunosuppressive drugs
al., 1995),VEGF-R1/Flt-1(Fong et al., 1995), and VEGF- FK506 and cyclosporin A have been helpful in dissecting
R3/Flt-4 (Dumont et al., 1998) are essential for the earli- this pathway. These chemically distinct natural products
est phases of endothelial cell differentiation from meso- bind at subnanamolar affinity to intracellular receptors,
dermally derived precursors as well as for vasculogen- forming inhibitory complexes. The resultant drug/pro-
esis and angiogenesis. Angiopoietin-1 (Ang-1) and its tein composite surface binds tightly to calcineurin and
tyrosine kinase receptor Tie-2/Tek and Tie-1, which func- prevents substrate access (Clipstone and Crabtree, 1992;
tion later than VEGF and its receptors during embryonic Liu et al., 1991).
development, are critical regulators of angiogenesis We have made null mutations of the NFATc4 gene
(Dumont et al., 1994; Puri et al., 1995; Sato et al., 1995; and show that mice doubly mutant for the NFATc3 and
Suri et al., 1996). During the angiogenic process, blood c4 genes have defects in vascular patterning and an-
vessels are remodeled to follow highly specific anatomic giogenesis. In addition, we have introduced a germline
mutation into mice which blocks the Ca2-dependent
phosphatase activity of calcineurin and find that the1 Corrrespondence: crabtree@cmgm.stanford.edu
2 These authors contributed equally to this work. phenotype of these CnB mutant mice closely resembles
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Figure 1. Targeted Disruption of the NFATc4 Gene
(A) Diagram of the wild-type NFATc4 allele, the targeting vector, and the recombined NFATc4 allele and 5 and 3 probes used for Southern
analysis.
(B) Southern blot probed with the 3 outside probe.
(C) Western blot of NFATc4/ and NFATc4/ E10.5 embryos. Lane 1: recombinant NFATc4. Lane 2: E10.5 NFATc4/ whole-cell extract.
Lane 3: E10.5 NFATc4/ extract.
(D) RNase protection assay of E9.5 and E10.5 RNA from NFATc4/ and NFATc4/mice.
that of the c3/c4 nulls. Our studies indicate that signals Defects in Vascular Patterning but Not Endothelial
transduced by Ca2, calcineurin, and NFATc3/c4 be- Differentiation in NFATc4/c3 Double
tween E7.5 and E8.5 in the tissues surrounding vessels Mutant Mice
promote the proper anatomical patterning of the devel- NFATc4/mice were viable and fertile and showed no
oping vascular system. major macroscopic or microscopic abnormalities after
36 months of observation. In situ hybridization indicated
that NFATc4 expression significantly overlaps with thatResults
of NFATc3 (data not shown), which is the closest homo-
log of NFATc4, suggesting that the two genes mightGeneration of Mice Bearing Null Mutations
have redundant functions. Hence, we generated doublein NFATc4
knock-out mice (c3/c4 null) by crossing the NFATc4/NFATc4 is one of four genes that encode the Ca2/cal-
mice with NFATc3/ mice (Oukka et al., 1998).cineurin-dependent subunits of NFAT transcription com-
We found that 98% of c3/c4 null embryos died in uteroplexes (Graef et al., 2001). We disrupted the NFATc4 gene
around E11.5. At E 9.5, most of the c3/c4 null embryosby homologous recombination, removing the transla-
exhibited no major morphological defects. At E10.5, thetional start site, the regulatory domain that controls cal-
c3/c4 null mice were alive, as indicated by the presencecineurin-dependent cytoplasmic-to-nuclear transloca-
of a heartbeat. These mutants were smaller, pale, andtion and part of the DNA binding domain (Figure 1A).
showed an underdeveloped yolk sac vasculature andSouthern blot analysis confirmed germline transmission
20% had enlarged pericardial sacs (data not shown).of the targeted allele (Figure 1B). No expression of en-
We sometimes observed the presence of blood in thedogenous protein (Figure 1C) or mRNA (Figure 1D) can
exocoelomic cavity, suggesting that the anemia seen inbe detected in NFATc4/ tissue, indicating that these
animals bear a null mutation. the embryos might be caused by extravasation of blood
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Figure 2. Disruption of Vascular Development in c3/c4 Null E10.5 Embryos
(A–D) Whole-mount immunostaining with anti-PECAM antibody. Arrows in (B) and (F) show abnormal branching of vessels into the somites.
The internal carotid artery seen in the wild-type (white arrowhead in [C]) is not fully developed in the c3/c4 null embryos (D). Branches of the
anterior cardinal vein (black arrowheads in [C]) are underdeveloped in c3/c4 null embryos and show abnormal communicating sprouts between
the main branches (D).
(E and F) H&E staining.
(G and H) Tunel staining shows no increase in apoptotic cell death .
(I and J) Whole-mount stains for smooth muscle actin. The c3/c4 null embryos show a failure of VSMCs to tightly associate with the dorsal
aorta (arrowhead in [J]).
(K and L) Sagittal sections at the level of the dorsal aorta (Da) stained with anti-smooth muscle actin antibody and (M–N) anti-desmin antibody
show a reduction of the number and a lack of tight association of VSMCs with endothelial cells in the dorsal aorta of the c3/c4 null embryo
(arrow in [L]).
(O and P) Electron micrographs of E10.5 yolk sacs. The cell layer adjacent to the mesothelium (Me  mesothelium) does not contain pericytes
(Pe, pericyte) in the c3/c4 null yolk sac (P) when compared to NFATc3/c4/ yolk sac (O). Both yolk sacs contain blood cells (B, blood cells).
The endodermal and mesothelial layer show a lack of contact in certain regions of the c3/c4 null yolk sac (arrowhead in [P]). (En, endothelial
cell; E, endoderm).
from the abnormal yolk sac vessels. Additionally, differ- In the trunk region, c3/c4 null embryos showed poorly
organized, dilated, intersomitic vessels that ignored somi-entiation of E8.5 and E10.5 c3/c4 null hematopoietic
precursors into erythroid and myeloid lineages in vitro tic boundaries (arrows in Figures 2B and 2F). At E10.5,
the heads of null embryos exhibited a more primitiveappeared to be normal, and expression of early hemato-
poietic markers such as GATA-1 was comparable to vasculature. The branches of the internal carotid artery
failed to develop in the c3/c4 null embryos. However,heterozygous littermates (data not shown).
The absence of organized vessels in the yolk sac was branches of the anterior cardinal vein were formed, but
were underdeveloped and showed abnormal communi-confirmed by PECAM staining, which revealed an en-
larged and disordered capillary plexus and poorly devel- cating sprouts between the branches (Figure 2D). In
severe cases, the development of the cranial vesselsoped vitelline vessels (data not shown). At E 9.5, the
vasculature of c3/c4 null embryos showed only mild was arrested at the primary capillary plexus stage and
branches of the anterior cardinal vein appeared fusedperturbations (data not shown), while a pronounced dis-
organization was apparent at E10.5. Although there was (data not shown).
The differentiation and proliferation of mutant endo-sprouting and branching of the initial vascular plexus in
E10.5 embryos, the major vessels including the inter- thelial cells was not impaired as suggested by the nor-
mal expression of endothelial markers such as PECAM,somitic vessels, branchial arch arteries, and cranial ves-
sels were severely disorganized (Figures 2A–2D and Flk-1, Tie-1, and Tie-2 (Figures 2A–2D and Figure 7). In
addition, mutant endothelial cells expressed the vascu-data not shown).
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lar adhesion molecule VE-cadherin and, in contrast to complexes by Ca2-dependent dephosphorylation of
the VE-cadherin knock-out endothelial cells (Carmeliet residues within the SP repeat motifs and the serine rich
et al., 1999), were also firmly attached to the basement region within the translocation domain at the N terminus
membrane (Supplemental Figures S2C–S2F, available of NFATc proteins. Dephosphorylation of these residues
online at http://www.cell.com/cgi/content/full/105/7/863/ is thought to unveil two nuclear localization sequences
DC1). This indicated that NFATc3/c4 are not required within NFATc, which leads to rapid nuclear localization.
for endothelial cell differentiation and vasculogenesis To determine if calcineurin regulates NFATc3 and c4
but are required for remodeling of the initial vascular function in vivo, we prepared a mouse strain in which
plexus and the ability of the developing vasculature to the signaling function (but not other possible functions
respond to patterning cues. of CnB) was disrupted. This was accomplished by add-
ing a peptide tag (FRB*) (see Supplemental Figure S1)
A Selective Defect in Smooth Muscle Cell to the C terminus of CnB (Griffith et al., 1995) (shown in
Recruitment to the Endothelium yellow in Figure 3A), which prevents the interaction of
of c3/c4 null Mice CnB with CnA and hence specifically interferes with the
A crucial stage of angiogenesis is the recruitment and Ca2-dependent activation of CnA catalytic activity. This
differentiation of mesenchymal cells into pericytes and allele is referred to as the CnB* allele. The basis of this
vascular smooth muscle cells (VSMC) to form a stable mutation is evident from the X-ray structure of the CnA-
vascular wall. This process is dependent upon recipro- CnB complex in which the C terminus of CnB (shown
cal signaling between endothelial cells and mesenchy- in yellow) has extensive interactions with residues 345
mal cells and is thought to involve angiopoietins and to 420 of the A chain (shown in gray in Figure 3A). The
their receptors, Tie-1 and Tie-2 (Sato et al., 1995; Suri FRB* tag was fused to the last codon of the CnB gene
et al., 1996) as well as Flt-1 (Fong et al., 1995), PDGF-B by homologous recombination (Figure 3B). The resultant
(Lindahl et al., 1997), tissue factor (Carmeliet et al., heterozygous (CnB/*) mice were found to have both
1996b), the TGF- pathway (Dickson et al., 1995; Oh et the predicted DNA rearrangement and the expected in-
al., 2000; Urness et al., 2000; Yang et al., 1999), and the crease in size of the CnB subunit (Figure 3C and data
transcription factor MEF2C (Bi et al., 1999; Lin et al., not shown). In addition, antibodies to the FRB* tag de-
1998). To test whether NFATc3/c4 were critical for this tected the slower migrating band, indicating that the
step in angiogenesis, we examined the expression of protein was in the correct reading frame (data not
smooth muscle actin and desmin in the mutant embryos. shown). In embryo extracts, the protein from the mu-
Whole-mount stains of c3/c4 null E10.5 embryos tated allele was expressed at near wild-type levels and,
showed poor association of smooth muscle actin posi- as predicted from the structure, did not interact with
tive cells with the aortic wall and irregular dilations of the catalytic A subunit. (Figures 3C and 3D). In CnB*/*
the aorta (arrowhead in Figure 2J), while smooth muscle mice, there was no detectable Ca2-dependent dephos-
staining within the somites appeared normal. Immuno- phorylation of NFATc4, indicating a complete loss of
staining revealed that the developing vessels of c3/c4 calcineurin phosphatase activity (Figure 3E).
null embryos had fewer cells expressing smooth muscle In vitro experiments and assays with calcineurin inhib-
actin and desmin (Figures 2K–2N) and that these cells itors indicated that the dephosphorylation of NFATc by
were usually distributed in the space around the vessel calcineurin induces cytoplasmic-to-nuclear transloca-
rather than directly adjacent to the vessel (arrow in Fig- tion of these transcription factors (Clipstone and Crabtree,
ure 2L). The reduction of supporting cells was not due 1992; Flanagan et al., 1991). The CnB*/* mice, however,
to apoptosis or a defect in cell proliferation since there provided the first opportunity to genetically examine this
was no difference between mutant embryos and their in vivo. Endocardial cells of wild-type embryos ex-
littermates in Tunel assays or immunostains for Ki-67,
pressed NFATc1 at E9.5 and the protein was nuclear in
a nuclear antigen expressed in proliferating cells (Fig-
the majority of cells (Figure 3F). In contrast, in CnB*/*
ures 2G and 2H and data not shown).
embryos, NFATc1 was cytoplasmic in all cells (FigureMicroscopically, both arteries and veins were affected
3G). Thus, under physiological conditions, calcineurinand showed thin, sometimes broken vessel walls with
is indeed necessary for the nuclear localization ofextravasation of erythrocytes into the surrounding tis-
NFATc1 in endocardial cells, as first demonstrated withsues (data not shown). Pericytes were absent in the meso-
biochemical reconstitution studies using the inhibitorsthelial layer and defective formation of contacts between
FK506 and CsA (de la Pompa et al., 1998; Flanagan etendodermal and mesothelial layers in the yolk sacs of
al., 1991). This data is consistent with the thought thatc3/c4 null embryos was observed by electron micros-
NFATc family members are both signal transducers andcopy (Figures 2O and 2P). These observations indicated
transcription factors.that NFATc3/c4 are required for the recruitment of vas-
cular smooth muscle and pericyte precursors to the
Vascular Defects in the CnB Mutant Embryosdeveloping vessel wall and for the tight interaction be-
Resemble Those of the c3/c4 Null Micetween endothelial and perivascular supporting cells.
Heterozygous CnB/* mice were indistinguishable from
wild-type littermates and have been followed for 6 gen-Generation of an Allele of CnB that Cannot
erations over 22 months with no detectable abnormalities.Activate the Phosphatase Activity
These results indicate that the FRB* tag on the CnBof Calcineurin A in Response
protein did not have a dominant-negative effect on cal-to Ca2 Signaling
cineurin function, nor was it likely to produce a gain-of-In vitro studies have indicated that calcineurin directly
controls the activity of the cytoplasmic subunits of NFAT function. No viable adult CnB*/* mice were found. About
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Figure 3. Generation of a Mouse Strain Carrying a CnB Mutant Allele that Is Unable to Interact with CnA
(A) Crystal Structure of the calcineurin complex showing the area of interaction between the C-terminal loop of the A chain (gray and light
blue) and the B chain (green and dark blue). The arrow indicates the site (shown in yellow) of addition of the FRB* tag.
(B) Genomic locus, targeting vector, and the targeted CnB locus showing the insertion of the FRB* sequence at the C terminus of the CnB
gene. H, HindIII; X, XbaI.
(C) Western blot of wild-type, CnB/* and CnB*/* embryo extracts with anti-CnB antibody.
(D) Failure of the mutant CnB subunit to associate with the CnA subunit. Brain extracts of a CnB/* mouse were prepared and immunoprecipitated
with the indicated antibodies. Precipitates were Western blotted with the anti-CnB antibody.
(E) Absence of calcineurin activity in CnB*/* mice. Anti-NFATc4 Western blot of extracts from the wild-type and CnB*/* mice. Note that the
dephosphorylated band in the wild-type extract is absent from the CnB*/* extract.
(F andG) NFATc1 fails to translocate to the nucleus in the endocardium of CnB*/* embryos. At E9.5, NFATc1 protein is nuclear in CnB/
endocardium (F) but is cytoplasmic in CnB*/* embryos (G). Green, NFATc1 staining. Blue, DAPI.
50% of the E10.5 CnB*/* embryos and all of the E11.5 littermates at E8.5, except in some rare cases where
the pericardial sacs of the CnB*/* embryos were slightlyCnB*/* embryos examined were not viable. CnB*/* mice
were macroscopically indistinguishable from wild-type enlarged (data not shown).
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Figure 4. Defective Vascular Organization in CnB*/* Embryos
(A–H) Whole-mount immunostaining with anti-PECAM1 antibody: At E8.5-8.75, most CnB*/* embryos (B) are indistinguishable from wild-type
controls (A). At E9.5, CnB*/* embryos have highly disorganized, syncitial intersomitic (D) and head (F) vessels compared to the organized
vascular network seen in the wild-type embryo (C and E). The yolk sacs of E10.5 CnB*/* embryos (H) appear arrested at the stage of the primary
vascular plexus and lack the vitelline vessels seen in the wild-type yolk sac (arrows in [G]).
(I and J) Whole-mount stains for smooth muscle actin (SmAc) at E10.5.
(K and L) Transverse sections at the level of the dorsal aorta stained with anti-SmAc at E10.5 show a layer of VSMCs around the wild-type
dorsal aorta at E10.5 and a severe reduction of the number of VSMCs adjacent to the wall of the dorsal aorta in the CnB*/* embryo.
(M and N) Desmin stains of the dorsal aorta.
(O and P) Electron micrographs of E9.5 dorsal aorta (magnification 700). There is a reduction in perivascular supporting cells surrounding
the dorsal aorta and breaks in the wall of the dorsal aorta in the CnB*/* embryo (arrow in [P]). (En, endothelial cell; Sm, vascular smooth
muscle cell; Da, dorsal aorta).
Beginning at E9.5, the CnB*/* embryos start to develop lacking the vitelline vessels (Figures 4G and 4H). As in
the c3/c4 null embryos, expression of endothelial differ-defects similar to those observed in the c3/c4 null em-
bryos. E9.5 CnB*/* embryos were alive, but smaller than entiation markers, endothelial cell morphology, as well
as adhesion to the basement membrane, was normal intheir littermates. However, the number of somites in the
mutants was only reduced by 1 or 2. By E9.5, about 40% the CnB*/* embryos (Figures 4O–4P, Figure 7, and Sup-
plemental Figure S2). These vascular defects appearedof the homozygous embryos had significantly enlarged
pericardial sacs. Although the primary vasculature was similar to, but more severe, than the defects found in
the c3/c4 null embryos, suggesting that other NFATcdeveloped in CnB*/* embryos, it failed to remodel to the
structured pattern of the wild-type vasculature (Figures family members and/or other calcineurin substrates
contribute to the phenotype.4A–4F). The dorsal aorta and intersomitic vessels were
formed at E8.75 (Figures 4A and 4B), indicating that vascu- Similar to the c3/c4 null embryos, whole-mount stains
of CnB*/* embryos showed poor association of smoothlogenesis occurred normally. At later stages, the vessels
became progressively disorganized, characterized by muscle actin positive cells with the aortic wall and irregu-
lar dilations of the aorta, while the somites appeared nor-excessive fusion into irregular dilated vessels and a fail-
ure to follow normal anatomical pathways as in the c3/c4 mal (Figures 4I and 4J). Immunohistochemical analysis
of desmin and smooth muscle actin expression showednull mice (Figures 4D and 4F). This indicates that patterning
cues that normally guide vessels and prevent vessel severe reduction of perivascular supporting cells (Fig-
ures 4K–4N).fusion are defective in the CnB*/* embryos. Proper angi-
ogenesis of the yolk sac vasculature of CnB*/* embryos The endothelial cells lining the major vessels appeared
ultrastructurally normal (Figures 4O and 4P). Consistentnever occurred, resulting in a primitive capillary plexus
NFAT Signaling in Angiogenesis
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with the light microscopic analysis, there was a marked c3/c4 null and CnB*/* mice show severe angiogenic ab-
normalities at the time that the heart appears morpho-reduction of pericytes and vascular smooth muscle cells
surrounding the aorta and discontinuities of the vascular logically normal, we conclude that defects in heart de-
velopment do not account for the angiogenic defects.wall (Figures 4O and 4P), explaining the frequently ob-
served hemorrhage in the mutant embryos. These ob- These studies, however, do not preclude a critical role
for NFATc3/c4 and CnB in later cardiac development orservations indicated that calcineurin/NFAT signaling is
required for the recruitment of vascular smooth muscle in the myocardial hypertrophic response.
and pericyte precursors to the developing vessel wall.
This defect is unlikely to be intrinsic to smooth muscle Identification of Calcineurin/NFAT Target Genes
cells since, in contrast to the MEF2C mutant mice (Lin in the E10.5 Embryo
et al., 1998), the organization of the somitic smooth Suprisingly, most of the identified regulators of vascular
muscle was not disturbed. development were expressed at normal levels in the
c3/c4 null and CnB*/* mice (Figure 7). Exceptions in-
cluded VEGF-A, Flt-1, and adrenomedullin, which wereCalcineurin Phosphatase Activity Is Essential
between E7.5 and E8.5 for overexpressed by several-fold in c3/c4 null and CnB*/*
embryos (Figure 7). In addition, administration of CsAVascular Development
To determine the time during development when cal- during the critical E7.5 to E8.5 period led to overexpres-
sion of the same genes. Induction of VEGF-A mRNAcineurin signaling is essential, we made use of the highly
specific, rapidly acting and reversible inhibitor of cal- appears not to be caused by hypoxia, since other hy-
poxia-induced genes such as erythropoietin, HIF1-,cineurin phosphatase activity, cyclosporin A. Injection
of CsA into pregnant mice between days 7.5 and 8.5 and Tie-2 were not induced (Figure 7B). We also exam-
ined the expression of VEGF-A by in situ hybridizationbut not earlier or later reproduced the vascular develop-
mental defects seen in CnB*/* and c3/c4 null embryos (Fig- and found that the increase was most pronounced in the
neural tube, somites and heart (Supplemental Figuresures 5A–5C). These embryonic CsA levels completely
blocked the ability of calcineurin to dephosphorylate S2G–S2K). These results suggest that NFAT signaling
either directly represses the VEGF-A gene or activatesembryonic NFATc4, assayed by Western blots of whole
embryo extracts (Figure 5D). Similar results were ob- a repressor of VEGF-A production.
Since ephrins and their receptors also play criticaltained with FK506 (data not shown). PECAM staining of
E10.5 embryos taken from these mothers indicated that roles in vascular development, we assayed the expres-
sion of all ephrins and Eph-receptors important in angio-while endothelial cells did differentiate, there was a fail-
ure of vascular organization with defects similar to those genesis (Adams et al., 1999; Gerety et al., 1999; Wang et
al., 1998). Again these were expressed at normal levelsof the CnB*/* embryos. The temporally selective action
of CsA could not be due to degradation of the drug, (Supplemental Figure S3). We also monitored the ex-
pression pattern of ephrinB2 by whole-mount stainingfailure of placental transfer, or embryonic metabolism
of the drugs, since similar levels of CsA were achieved for -galactosidase in CsA-treated ephrinB2taulacZ em-
bryos (Wang et al., 1998) and found that, while the overallduring the critical period and after it. In addition, we
found that even at the time that CsA administration had expression of ephrinB2taulacZ was unaltered, the pattern
of vascular expression reiterated the CsA-induced vas-no developmental effect, it still produced hyperphos-
phorylation of NFATc4, indicating that the drug effectively cular abnormalities (Supplemental Figure S3B).
Thus, in the absence of NFATc3/c4 signaling, mostgained access to the embryo and blocked calcineurin
activity (data not shown). The observation that CsA ad- of the known vascular growth and differentiation factors
and receptors were expressed normally.ministration mimics the phenotype of the CnB*/* mutants
indicates that in early mammalian development, CsA is
a highly specific inhibitor of calcineurin function and is NFATc4 Is Expressed in the Neural Tube
unlikely to have other developmentally critical targets. and Somites during the Time that It Is Critical
to Angiogenesis
Determination of the developmental window during whichAngiogenic Defects in the c3/c4 Null and CnB*/*
Mice Are Not Related to Defective Ca2/calcineurin/NFAT signaling is necessary for angio-
genesis (Figure 5), opened the unusual opportunity toMyocardial Development
Calcineurin and NFATc4 have been shown to play impor- ask where the protein was expressed at the time that it
was performing its critical developmental functions. Bytant roles in mediating the response of the adult heart
to hypertrophic stimuli (Molkentin et al., 1998). Since the both in situ hybridization and by immunoflourescence,
NFATc4 was expressed in the neural tube and somiteshypertrophic response often reiterates embryonic cardiac
development (Olson and Williams, 2000), we considered during the critical E7.5 to E8.5 period (Figure 8A). Whole-
mount fluorescent staining of E8.5 embryos also showedthe possibility that the angiogenic defects seen in the
c3/c4 null and CnB*/* mice could be secondary to a that NFATc4 was nuclear at this time, indicating that
the pathway was active in these cells (Figure 8A). Thisdefect in cardiac development. However, the c3/c4 null
and CnB*/* embryos showed a normal heart beat, and observation is consistent with the biochemical observa-
tion that the protein is dephosphorylated at E8.5 (datano apparent defects in cardiac morphology were visible
(Figure 6). The expression of myocardial markers such not shown). To help determine if the NFAT signaling
occurs in the vascular endothelium or the surroundingas smooth muscle actin, desmin, and MLC-2V in the c3/
c4 null and CnB*/* mutant hearts is comparable to con- tissues, embryos were costained for Tie-2 and NFATc4.
Although NFATc4 in the trunk regions seemed to betrol littermates (Figures 6C–6H and 6K–6P). Since the
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Figure 5. Calcineurin Functions Between E7.5 and E8.5 to Transduce Signals Required for Vascular Development
PECAM staining showing similar abnormalities in vascular development in E10.5 CnB*/* embryos (B) and embryos from mothers treated with
25 mg/kg CsA twice per day at E7.5 and E8.5 (C) when compared to untreated E10.5 embryos (A). (D) Maternal administration of CsA either
from E7.5–E9.5 (lane1) or for 3 hr at E10.5 (lane2) induced hyperphosphorylation of the NFATc4 protein compared to nontreated embryos
(lane3). (E) Experimental strategy to identify the window in which calcineurin is required for angiogenesis. The gray bars denote the time of
CsA administration and the red region is the critical period for Cn/NFATc signaling.
located predominantly in the neural tube and somites surrounding cells, there is probably some low degree
of expression in endothelial cells.rather than the endothelial cells, some degree of overlap
in fluorescence was observed (Figure 8A). To further In the c3/c4 null and CnB*/* embryos, we found that
vessels invade the neural tube and somites to an extentclarify the localization of NFATc4 in embryos, we disso-
ciated E8.5 embryos and used fluorescence activated that greatly exceeds the normal pattern (Figures 2 and
4; data not shown), suggesting that NFAT signaling pre-cell sorting (FACS) to separate endothelial cells based
on PECAM and Flk-1 expression. The amount of NFATc4 vents abnormal growth of vessels into these tissues.
Tie-2 fluorescent whole-mount staining of CsA-treatedin the double positive cells (PECAM and Flk-1 positive)
was then compared to the amount of NFATc4 in the embryos at E9.0 also showed aberrant branches of inter-
somitic vessels invading the somites (Figure 8C). In situdouble negative cells by semiquantitative RT-PCR. The
double negative cells expressed a 5- to 10-fold higher hybridization of embryos for VEGF-A mRNA shows that
its expression was enhanced (possibly derepressed) inlevel of NFATc4 than the double positive endothelial popu-
lation. Thus, while NFATc4 is preferentially expressed in somites and neural tube (Supplemental Figures S2G–
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Figure 6. Early Cardiac Development Appears Normal in c3/c4 null and CnB*/* Embryos
(A and B) Ventricular wall of c3/c4/ and c3/c4 null embryos at E10.5, H&E; (C and D) Desmin-immunostaining; (E and F) PECAM-
immunostaining; and (G and H) 35[S] in situ hybridization of myosin light chain (MLC2V).
(I–P) Cardiac morphology in CnB/ and CnB*/* embryos at E9.5. (I and J) H&E; (K and L) Desmin-immunostaining; (M and N) SmAc-
immunostaining; and (O and P) 35[S] in situ hybridization of MLC2V.
S2J). This finding suggests that regionally specific NFAT sults indicate that Ca2/calcineurin/NFAT signaling pat-
terns the vascular system by controlling regional expres-signaling (in the somites and neural tube) directly or
indirectly represses VEGF-A expression, thereby pre- sion of VEGF-A and probably other regulators of vessel
venting uncontrolled growth of vessels into regions such development (Figure 8D). This hypothesis is based on
as the neural tube, where vessels must observe very the often-made assumption that proteins have their
specific pathways. (Figure 8D). function in locations of highest expression and will have
to be tested by regional specific deletion of the compo-
nents of this signaling pathway.Discussion
The relationship between NFAT signaling and VEGF-A
expression may well be indirect since the lag time be-NFAT Signaling Appears to Suppress Local
tween CsA administration to the mother and inductionVascular Development
of VEGF-A in the embryo is in excess of 3 hr. This delayArteries and veins of adult mammals follow precise ana-
is probably not related to pharmacological barriers,tomical paths that show relatively little variation between
since 30 min after CsA administration to the mother, weindividuals. This stereotyped anatomy suggests that some
were able to detect complete inhibition of calcineurinform of guidance must be provided to the growing ves-
phosphatase activity measured on endogenous embry-sel. Such guidance cues are likely to involve both posi-
onic NFATc4 (results not shown). Thus, a possible sce-tive cues that direct vessels into specific regions and
nario is that NFAT signaling suppresses an inducer ofnegative cues that prevent major vessels from devel-
VEGF-A expression or alternatively regulates the ex-oping within structures that require a very specific pat-
pression of a negative vascular guidance cue.tern of vascularization. Our results indicate that signal-
A vascular patterning defect reminiscent of the oneing through Ca2/calcineurin /NFATc3,c4 mediates a
seen in the c3/c4 null and CnB*/* mice has been describednegative signal preventing aberrant growth of vessels.
in mice having mutations in ephrinB2 as well as EphB2/When signaling by this pathway is prevented, either by
EphB3 double mutants (Adams et al., 2001, 1999). Ephmutation of CnB or NFATc3/c4 or by inhibition of cal-
receptors and their ligands are probably involved in par-cineurin with CsA, vessels grow into regions where
NFATc3/c4 are expressed at highest levels. These re- acrine signaling between the mesenchyme and the
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Figure 7. Definition of a Cluster of Genes Regulated by c3/c4 null, CnB*/* , and CsA
(A) RNase protection assay shows selective overexpression of VEGF-A (determined by phosphoimaging) and normal expression of iNOS, IGF-a,
Flt-4, Tie-1, Tie-2, FGF-2, neuregulin, and VEGF-C in c3/c4 null, CnB*/*, and CsA-treated embryos (three hours after the 50 mg/kg injection
the concentration of CsA in maternal blood was 5.15 g/ml of whole blood and the CsA concentration in the embryos was 1.94 g/ml of
embryo extract). The CnB*/* lane was underloaded, as judged by L32 and GAPDH levels.
(B) A cluster of coregulated genes was defined by analysis of transcript arrays (Affymetrix), RPA assays, and quantitative RT-PCR. Specific
attention has been given to those genes required for cardiovascular development. All results are expressed as a fold change compared to
the age-matched, wild-type sample. “^” denotes RPA result, “*” denotes Affymetrix transcript array result, “” denotes RT-PCR result, and
“NC” denotes no change.
growing blood vessel and hence, EphB2, which is ex- function do not underlie the early angiogenic defects
observed in CnB*/*, c3/c4 null mice, present evidencepressed in the mesenchyme adjacent to endothelial
cells, seems a possible candidate for a receptor that strongly indicates that these molecules have critical
roles later in myocardial development and functionregulates NFATc3/c4 at this time in development.
(Olson and Williams, 2000).
Signaling by NFATc1 in the endocardium is essentialDefects in Cardiac Development Do Not Account
for development of heart valves (de la Pompa et al.,for the Early Embryonic Lethality in the CnB
1998; Ranger et al., 1998). These defects also have noand c3/c4 Null Mice
role in generating the angiogenic phenotypes we ob-Calcineurin and NFATc4 have been shown to be regula-
served, since the mice completely lacking NFATc1 func-tors of myocardial fiber hypertrophy in response to
tion do not die until E13.5, while the CnB*/* and c3/c4stress in the adult murine heart (Molkentin et al., 1998).
null mice die before cardiac valve function becomesHowever, myocardial dysfunction does not seem to ac-
necessary. In addition, the NFATc1 mutant mice have nocount for the phenotypes we observed in either the
defects in angiogenesis detectable by PECAM staining.CnB*/* or the c3/c4 null mice. Heart morphology and
heartbeat appeared normal even when the angiogenic
defects in the c3/c4 null and CnB*/* mice were far ad- Defective Angiogenesis in CnB
and c3/c4 Null Micevanced (Figure 6 and data not shown). In addition, the
expression of a number of cardiac markers was normal. Several observations indicate that NFAT signaling may
be necessary for both vascular organization as well asThe development of relatively normal cardiac trabecu-
lations in the NFATc3/c4 and CnB mutant mice contrasts vascular assembly. Our analysis of the c3/c4 null and
CnB*/* embryos revealed that both the yolk sac and thewith the severe defects in trabeculation observed in
mice lacking neuregulin and its receptors (Erickson et embryo initiate vasculogenesis properly, but fail to re-
cruit pericytes and VSMCs to form a stable vascularal., 1997; Gassmann et al., 1995; Lee et al., 1995; Meyer
and Birchmeier, 1995), or angiopoietin and its receptors wall. This process is dependent upon interactions of
endothelial cells with mesenchymal cells. Light micro-(Dumont et al., 1994; Puri et al., 1995; Sato et al., 1995;
Suri et al., 1996), or MEF2C (Lin et al., 1997). Although scopic and ultrastructural analysis showed that cal-
cineurin/NFAT signaling was required for the recruitmentour observations indicate that defects in myocardial
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Figure 8. NFATc4 Shows Nuclear Localization in Somites and Neural Tube of E8.5 Embryos and Is Expressed at Very Low Levels in
Endothelial Cells
(A) Fluorescent whole-mount immunohistochemistry with anti-NFATc4 (green) and anti-Tie-1 (red) antibodies on E8.5 embryos. Blue, DAPI.
The staining in the somites and neural tube is nuclear (A) and is absent in the control samples with the secondary antibody alone (not shown).
(B) FACS analysis of dissociated cells from whole embryos using antibodies to Flk-1 and PECAM. The right panel shows the results of semi-
quantitative RT-PCR for NFATc4 and Flk-1 on the PECAM/Flk-1 double-positive cells and PECAM/Flk-1 double-negative cells.
(C) Whole-mount Tie-2 staining of CsA-treated (E7.58.5) embryos at E9.0 vessels shows invasion of the somites by aberrant branches of
intersomitic vessels (white arrow in [C]).
(D) Localized NFAT signaling in the somites and neural tube leads to a suppression of vessel growth into the somites and neural tube.
Cell
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RNA Expression Analysisof vascular smooth muscle and pericyte precursors to
The NFATc4 probe for ribonuclease protection was an EcoRI/BamHIthe developing vessel wall without disrupting endothelial
fragment containing part of exon 2 of the murine NFATc4 gene.or smooth muscle cell specification. However, the defect Transcript arrays were done with biotinylated cRNA prepared by
that we see is not intrinsic to smooth muscle cells since standard techniques using the Affymetrix murine 11k and 36k gene
somitic smooth muscle was correctly patterned and dif- chips. Quantitative RT-PCR was done by standard techniques on
a Bio-Rad Icycler.ferentiation markers were expressed.
The angiogenic defects in the c3/c4 null and CnB*/*
Flow Cytometryembryos differ from the defects observed in MEF2C and
E8.5 embryos and yolk sacs were dissociated and stained with
PDGF pathway mutant mice. In MEF2C mutant embryos, FITC-conjugated anti-PECAM (CD31, clone MEC 13.3, Pharmingen)
differentiation of smooth muscle cells is completely antibody and PE-conjugated anti Flk-1 antibody (clone Avas 121,
Pharmingen). All sorts and analyses were performed on a FACSblocked in somites, heart ventricle, and in perivascu-
Vantage flow cytometer (Becton-Dickinson). Dead cells were ex-lar cells (Lin et al., 1998). The defects in PDGF-B/and
cluded by gating on forward and side scatter as well as by eliminat-PDFGR/ embryos occur at a later stage in embryonic
ing propidium iodine positive cells and 6.5  104 CD31/Flk-1 and
development (Hellstro¨m et al., 1999) and PDGF-B is ex- CD31/Flk-1 cells were sorted. RNA was prepared by standard tech-
pressed at normal levels in the c3/c4 null and CnB*/* em- niques and one-step RT-PCR for NFATc4 and Flk-1 was performed
on RNA from 812, 162, and 32 cells. NFATc4 sense:gaagctaccctcbryos. Since perivascular mesenchyme expresses high
cggtacagag; antisense:gcttcatagctggctgtagcc; Flk-1 sense: cagaacaglevels of NFATc4 (Figure 8), NFAT signaling may also
taagcgaaagagccggccag antisense:aagcagcacctctctcgtgatttccaggagbe necessary in the perivascular supporting cells to as-
semble the vessel wall. Several features distinguish the Acknowledgments
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